Alpine Woods Capital Investors’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Alpine Woods Capital Investors’s Portfolio BBC Stock Details BBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-19,500	Closed	-$742K	–	261
2019 Q4	$742K	Sell	19,500 -5,000	-20%	-$149K	0.14%	140
2019 Q3	$584K	Hold	24,500	–	–	0.11%	152
2019 Q2	$706K	Hold	24,500	–	–	0.15%	144
2019 Q1	$698K	Hold	24,500	–	–	0.15%	143
2018 Q4	$569K	Buy	+24,500	New	+$668K	0.14%	154

Other funds holding BBC

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

NCM

Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Alpine Woods Capital Investors's BBC Position: Q1 2020 in Review

Alpine Woods Capital Investors sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q1 2020, closing a stake of 19,500 shares — an estimated $742K sold.

Alpine Woods Capital Investors first reported a position in BBC in Q4 2018 and held it in 5 quarters. The position peaked at $742K in Q4 2019. 15 funds tracked by Wall St. Rank hold BBC as of Q1 2020.

Alpine Woods Capital Investors reported no remaining Virtus Biotech Clinical Trials ETF position as of Q1 2020 after selling out during the quarter.
Alpine Woods Capital Investors sold 19,500 Virtus Biotech Clinical Trials ETF shares in Q1 2020, an estimated $742K.
Alpine Woods Capital Investors first reported a position in Virtus Biotech Clinical Trials ETF in Q4 2018 and held it in 5 quarters.
Alpine Woods Capital Investors's Virtus Biotech Clinical Trials ETF position peaked at $742K in Q4 2019.
15 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q1 2020.

Based on Alpine Woods Capital Investors's 13F filing for Q1 2020, filed 4 May 2020.